We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.09B
AUM Growth
+$15.8M
Cap. Flow
-$86M
Cap. Flow %
-4.12%
Top 10 Hldgs %
18.08%
Holding
266
New
20
Increased
45
Reduced
134
Closed
56

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.8M
2
TENB icon
Tenable Holdings
TENB
+$16.8M
3
LIVN icon
LivaNova
LIVN
+$14M
4
FN icon
Fabrinet
FN
+$13.9M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
ACDC icon
ProFrac Holding
ACDC
+$26.1M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$21.4M
3
CUBI icon
Customers Bancorp
CUBI
+$16M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$14.6M
5
PRFT
Perficient Inc
PRFT
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.06%
2 Technology 16.79%
3 Industrials 15.69%
4 Consumer Discretionary 14.06%
5 Financials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNK icon
151
Cinemark Holdings
CNK
$3.82B
$833K 0.04%
56,335
– –
TSLA icon
152
Tesla
TSLA
$1.24T
$789K 0.04%
3,805
+271
+8% +$47.3K
UNH icon
153
UnitedHealth
UNH
$382B
$782K 0.04%
1,655
– –
ABT icon
154
Abbott
ABT
$180B
$769K 0.04%
7,598
– –
HES
155
DELISTED
Hess
HES
$749K 0.04%
5,662
+1,462
+35% +$204K
KEYS icon
156
Keysight
KEYS
$54.5B
$732K 0.04%
4,533
+835
+23% +$142K
HAL icon
157
Halliburton
HAL
$27.9B
$719K 0.03%
22,723
+3,091
+16% +$114K
MKTX icon
158
MarketAxess Holdings
MKTX
$4.15B
$714K 0.03%
1,825
-235
-11% -$83.2K
CSGP icon
159
CoStar Group
CSGP
$11.3B
$712K 0.03%
10,341
-3,130
-23% -$231K
MPB icon
160
Mid Penn Bancorp
MPB
$942M
$697K 0.03%
27,219
– –
SPGI icon
161
S&P Global
SPGI
$126B
$682K 0.03%
1,977
– –
SCHW
162
Charles Schwab
SCHW
$177B
$671K 0.03%
+12,805
New +$938K
NFE icon
163
New Fortress Energy
NFE
$101M
$658K 0.03%
22,358
+9,345
+72% +$329K
COST icon
164
Costco
COST
$415B
$646K 0.03%
1,300
+370
+40% +$181K
BC icon
165
Brunswick
BC
$5.19B
$633K 0.03%
7,725
-81
-1% -$6.7K
ALNY icon
166
Alnylam Pharmaceuticals
ALNY
$36.3B
$627K 0.03%
3,132
+575
+22% +$121K
META icon
167
Meta Platforms (Facebook)
META
$1.51T
$625K 0.03%
2,948
-225
-7% -$38.3K
POOL icon
168
Pool Corp
POOL
$6.7B
$593K 0.03%
1,733
-11
-0.6% -$3.9K
SMG icon
169
ScottsMiracle-Gro
SMG
$4.03B
$592K 0.03%
8,487
-16,570
-66% -$1.19M
IIIV icon
170
i3 Verticals
IIIV
$395M
$556K 0.03%
22,649
+20,649
+1,032% +$542K
RMD icon
171
ResMed
RMD
$28.3B
$547K 0.03%
2,499
-15
-0.6% -$3.25K
APH icon
172
Amphenol
APH
$188B
$535K 0.03%
13,082
-136
-1% -$5.37K
TER icon
173
Teradyne
TER
$54.8B
$520K 0.02%
4,839
-49
-1% -$5.01K
UBER icon
174
Uber
UBER
$134B
$505K 0.02%
+15,920
New +$505K
TREX icon
175
Trex
TREX
$4.51B
$498K 0.02%
10,237
-3,913
-28% -$198K
5 6
7
8 9

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Emerald Advisers held 266 positions worth $2.09B, up 0.76% from $2.07B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $86M in Q1 2023, closing 56 positions and reducing 134 holdings. Its most notable exit was ProFrac Holding, an estimated $26.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in LivaNova worth $12.1M.

  • Emerald Advisers's largest Q1 2023 buy was LivaNova: 277,388 shares worth $12.1M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $18.8M increase.
  • Emerald Advisers's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $21.4M.
  • Emerald Advisers fully exited ProFrac Holding in Q1 2023, selling an estimated $26.1M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.09B portfolio in Q1 2023.
  • Emerald Advisers opened 20 new positions and closed 56 in Q1 2023.
  • Emerald Advisers's portfolio value rose 0.76% quarter-over-quarter to $2.09B.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.